Suivre
Sier CFM
Sier CFM
Department of Surgery, Leiden University Medical Center, Netherlands
Adresse e-mail validée de lumc.nl
Titre
Citée par
Citée par
Année
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
CFM Sier, F Kubben, S Ganesh, MM Heerding, G Griffioen, ...
British journal of cancer 74 (3), 413-417, 1996
4221996
Matrix metalloproteinase-14 (MT1-MMP)–mediated endoglin shedding inhibits tumor angiogenesis
LJAC Hawinkels, P Kuiper, E Wiercinska, HW Verspaget, Z Liu, E Pardali, ...
Cancer research 70 (10), 4141-4150, 2010
3582010
Use and efficacy of bone morphogenetic proteins in fracture healing
SN Lissenberg-Thunnissen, DJJ de Gorter, CFM Sier, IB Schipper
International orthopaedics 35, 1271-1280, 2011
3402011
Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts
L Hawinkels, M Paauwe, HW Verspaget, E Wiercinska, JM Van Der Zon, ...
Oncogene 33 (1), 97-107, 2014
3102014
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients
CFM Sier, R Stephens, J Bizik, A Mariani, M Bassan, N Pedersen, ...
Cancer research 58 (9), 1843-1849, 1998
2511998
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
N Sidenius, CFM Sier, H Ullum, BK Pedersen, AC Lepri, F Blasi, ...
Blood, The Journal of the American Society of Hematology 96 (13), 4091-4095, 2000
2492000
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
LJAC Hawinkels, K Zuidwijk, HW Verspaget, ESM de Jonge-Muller, ...
European journal of cancer 44 (13), 1904-1913, 2008
2412008
Urokinase receptor and colorectal cancer survival
SJ Ganesh, CFM Sier, MM Heerding, G Griffioen, CBHW Lamers, ...
The Lancet 344 (8919), 401-402, 1994
2291994
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
S Ganesh, CFM Sier, G Griffioen, HJM Vloedgraven, A de Boer, ...
Cancer Research 54 (15), 4065-4071, 1994
2151994
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer
FJGM Kubben, CFM Sier, LJAC Hawinkels, H Tschesche, W van Duijn, ...
European journal of cancer 43 (12), 1869-1876, 2007
1912007
Increased mucosal matrix metalloproteinase-1,-2,-3 and-9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype
MJW Meijer, MAC Mieremet-Ooms, AM Van Der Zon, W van Duijn, ...
Digestive and Liver Disease 39 (8), 733-739, 2007
1842007
Expression of matrix metalloproteinases-2 and-9 in intestinal tissue of patients with inflammatory bowel diseases
Q Gao, MJW Meijer, FJGM Kubben, CFM Sier, L Kruidenier, W van Duijn, ...
Digestive and liver disease 37 (8), 584-592, 2005
1702005
Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo
N Sidenius, CFM Sier, F Blasi
FEBS letters 475 (1), 52-56, 2000
1682000
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
F Kubben, CFM Sier, MJW Meijer, M Van Den Berg, JJ Van Der Reijden, ...
British Journal of Cancer 95 (6), 744-751, 2006
1652006
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices
P Koolwijk, N Sidenius, E Peters, CFM Sier, R Hanemaaijer, F Blasi, ...
Blood, The Journal of the American Society of Hematology 97 (10), 3123-3131, 2001
1632001
Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis
M Paauwe, MJA Schoonderwoerd, RFCP Helderman, TJ Harryvan, ...
Clinical Cancer Research 24 (24), 6331-6344, 2018
1572018
Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage
D Gveric, R Hanemaaijer, J Newcombe, NA van Lent, CFM Sier, ...
Brain 124 (10), 1978-1988, 2001
1522001
Superoxide dismutases in relation to the overall survival of colorectal cancer patients
AML Janssen, CB Bosman, CFM Sier, G Griffioen, F Kubben, C Lamers, ...
British Journal of Cancer 78 (8), 1051-1057, 1998
1401998
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
F Kubben, CFM Sier, W Van Duijn, G Griffioen, R Hanemaaijer, ...
British journal of cancer 94 (7), 1035-1040, 2006
1322006
Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy
S Mustjoki, N Sidenius, CFM Sier, F Blasi, E Elonen, R Alitalo, A Vaheri
Cancer research 60 (24), 7126-7132, 2000
1312000
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20